#therapies

- Terns Pharmaceuticals, Inc. today announced presentation of preclinical data on its two lead programs at The ...

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...

The Ministry of Social Affairs is preparing the New Platform (NP) Social Rehabilitation Program 5.0 aimed at providing ...

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...

London School of Public Relations (LSPR) Jakarta is conducting a higher educational program for autistic children by ...

- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, ...

- Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue ...

A future where faecal transplants in China will cure conditions like autism, IBD, arthritis, Parkinson's disease and ...

- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...

- Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND clinical trial program evaluating ...

- Cook Medical officially opened its new state of the art South Asia Distribution Centre (SADC) in Singapore on 30th ...

Scientists in Singapore have made a big leap on research on the 'mini-brain'. These advanced mini versions of the ...

- HSRx Biopharmaceutical, a leading developer of polyfunctional-powered combination drugs for infectious ...

-    Merck's Consumer Health business takes the lead in addressing health and well-being challenges of ...

-606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 ...